Viewing Study NCT06224192


Ignite Creation Date: 2025-12-24 @ 3:53 PM
Ignite Modification Date: 2025-12-26 @ 4:55 PM
Study NCT ID: NCT06224192
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-08
First Post: 2024-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module